Provided by Tiger Trade Technology Pte. Ltd.

Sionna Therapeutics

6.46
+0.43007.13%
Post-market: 6.39-0.0697-1.08%19:48 EDT
Volume:1.41M
Turnover:8.90M
Market Cap:290.69M
PE:-2.98
High:6.48
Open:5.95
Low:5.93
Close:6.03
52wk High:54.97
52wk Low:4.01
Shares:45.00M
Float Shares:16.73M
Volume Ratio:1.21
T/O Rate:8.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1683
EPS(LYR):-1.8835
ROE:-32.34%
ROA:-21.54%
PB:1.09
PE(LYR):-3.43

Loading ...

Sionna Therapeutics Cut to Hold From Buy by Freedom Broker

Dow Jones
·
May 21

Sionna Therapeutics downgraded at Freedom Broker with unchanged target

TIPRANKS
·
May 20

Wedbush Sticks to Their Buy Rating for Sionna Therapeutics, Inc. (SION)

TIPRANKS
·
May 18

Sionna Therapeutics price target raised to $55 from $44 at Stifel

TIPRANKS
·
May 18

LifeSci Capital Reaffirms Their Buy Rating on Sionna Therapeutics, Inc. (SION)

TIPRANKS
·
May 16

RBC Capital Sticks to Its Sell Rating for Sionna Therapeutics, Inc. (SION)

TIPRANKS
·
May 14

Analysts Are Bullish on Top Healthcare Stocks: Metagenomi, Inc. (MGX), Sionna Therapeutics, Inc. (SION)

TIPRANKS
·
May 14

Stock Track | Sionna Therapeutics Soars 5.40% Intraday Bolstered by Analyst Support and Upcoming Conference Spotlight

Stock Track
·
May 14

Wedbush Remains a Buy on Sionna Therapeutics, Inc. (SION)

TIPRANKS
·
May 13

Sionna Therapeutics joins RBC Capital Markets Global Healthcare Conference fireside chat

Reuters
·
May 13

Sionna Therapeutics Price Target Maintained With a $58.00/Share by BTIG

Dow Jones
·
May 13

Sionna Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 12

Sector Update: Healthcare

MT Newswires Live
·
May 12

Sionna Therapeutics reports Q1 EPS (60c), consensus (50c)

TIPRANKS
·
May 12

Earnings Flash (SION) Sionna Therapeutics Posts Q1 Net Loss $0.60 a Share, vs. FactSet Est of $0.54 Loss

MT Newswires Live
·
May 12

Sionna Therapeutics Q1 EPS $(0.60) Misses $(0.51) Estimate

Benzinga Earnings
·
May 12

Sionna Therapeutics Q1 net loss widens, misses estimates

Reuters
·
May 12

Sionna Therapeutics Inc - Maintains Cash Position of $289.9 Mln; Expects to Fund Operations Into 2028

THOMSON REUTERS
·
May 12

Sionna Therapeutics Inc Q1 Income From Operations USD -29.599 Million

THOMSON REUTERS
·
May 12

Sionna Therapeutics Inc Q1 Basic EPS USD -0.6

THOMSON REUTERS
·
May 12